Professor Annelies Wilder-Smith is Full Professor with Tenure for Infectious Diseases Research at Lee Kong Chian School of Medicine, Nanyang Technological University. Her current research interests are vaccine preventable and emerging infectious diseases, with a focus on dengue, meningococcal disease, and influenza. Her general interests and expertise include travel and tropical medicine as well as vaccinology. In addition to epidemiological studies, she has led or co-led various clinical trials, in particular vaccine trials for the development of dengue and influenza vaccines. Currently, she is the Lead Principal Investigator and Coordinator of a large international research consortium, called DengueTools, funded with 5.6 million Euro funded by the European Commission: www.denguetools.net.
The DengueTools consortium has set out to develop novel strategies and tools for the surveillance and control of dengue. In 2015, Annelies Wilder-Smith was appointed Senior Advisor to the “Dengue Vaccine Initiative” (www.denguevacinnes.org). Furthermore, her more recent aim is to set up a controlled human infection platform in Singapore (CHIPS).
She has published more than 170 scientific papers in international peer reviewed journals, including the New England Journal of Medicine, the Lancet, Emerging Infectious Diseases Journal and Clinical Infectious Diseases Journal. In addition to multiple book chapters, she co-edited the book “Manual of Travel Medicine & Health” (Steffen/DuPont/Wilder-Smith, 2003 and 2007, B.C. Decker Inc) and “Travel Medicine: tales behind the science” (Wilder-Smith, Schwartz, Shaw; Elsevier, 2007) and authored the book “How to take a medical history in Chinese” (Armour Publishing ISBN 981-4045-29-2).
Annelies Wilder-Smith is the President-elect of the International Society of Travel Medicine, Past-President of the Asia Pacific Society of Travel Medicine, and was Chair of the Regional Conference of the ISTM in Singapore 2012 (www.apthc2012.org). Since 2006, she has served as co-editor of the annual revisions of WHO’s “International Travel and Health” (the “Green Book”), contributed to the WHO working group on yellow fever risk assessment, and serves on the WHO roster for the International Health Regulations Secretariat. In Singapore, she serves on various national committees, and was elected to Senator of the Academic Council, and serves on LKC PhD task force.
Professor Wilder Smith obtained her MD from the University of Heidelberg, Germany, in 1987, her Master in International Health from Curtin University in Australia, and her PhD from the University of Amsterdam, The Netherlands, in 2003. The topic of her PhD was on “W135 meningococcal disease in Hajj pilgrims”. Over the past 15 years she has developed and taught courses in global health, communicable diseases and travel medicine both in Singapore and beyond. She worked and lived in the Asia Pacific region for more than 18 years (China, Nepal, Papua New Guinea and since 1998 in Singapore). From 2011-2012, she was the Director of Master Programme in International Health at the Institute of Public Health, University of Heidelberg, Germany.
Her awards include the Myrone Levine Vaccinology Prize, the Honor Award for exemplary leadership and coordination in determining and communicating global yellow fever risk (National Centre for Zoonotic and Emerging Infectious Diseases, presented at the CDC Award Ceremony), Ashdown Oration, the Brocher Foundation Award, and awards for best oral presentations at scientific conferences.
Professor Wilder-Smith holds a guest professorship at the University of Umea, Sweden, and is adjunct professor at the University of Heidelberg, Germany. She serves on the editorial board for the Journal of Travel Medicine, is Advisor to GeoSentinel, Editorial Consultant to the Lancet, and also serves as volunteer consultant to various community development projects in Asia. Her vision is to build up global health teaching and research programmes in Singapore and beyond